New pre-clinical data on laquinimod in an experimental autoimmune uveitis model has been published as an abstract in the Journal of Immunology. May 1, 2020, 204 (1 Supplement) 150.18.
Laquinimod arrests development of experimental autoimmune uveitis (EAU) and inhibits related immune processes, in the context of altered gut microbiota. Biying Xu, Xiuzhi Jia, Jihong Tang, Rachel R Caspi and Igal Gery,. J Immunol May 1, 2020, 204 (1 Supplement) 150.18.
Read the abstract here.